AMEND news in Tag: net cancer day
NETs in RETS Webinar with Prof Karim Meeran
We were delighted that AMEND Trustee, Professor Karim Meeran, could join us for our webinar on Thursday 9th November, to explain the relation between neuroendocrine tumours (NETs) and rare endocrine tumour syndromes (RETS). You can now view the webinar recording on our YouTube Channel.
AMEND Attends INCA Summit
AMEND is a member of the International Neuroendocrine Cancer Alliance (INCA), the organisation responsible for NET Cancer Day (AKA Neuroendocrine Cancer Day). Each year, INCA holds a Summit where their member organisations from around the world can get together and discuss projects, plans, strategy, and also share best practice ideas with one another.
NETS in RETS
November 10th each year is NET Cancer Day, initiated by the International Neuroendocrine Cancer Alliance, of which AMEND is a member representing genetic neuroendocrine tumour syndromes. To better explain the link between NETs and RETS (rare endocrine tumours and syndromes), join us for our webinar, NETs in RETS, with Professor Karim Meeran on Thursday 9th November from 18:00-19:00.
AMEND Attends INCA SummitOn 26-27 September, AMEND CEO Jo Grey, was pleased to attend the first in-person Summit for 3 years of the International Neuroendocrine Cancer Alliance (INCA).